
Romano Drugs Private Limited
Manufacturer of API and intermediates for global export since 1996.
Manufacturer of API and intermediates for global export since 1996.
Romano Drugs Private Limited (RDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 September 1996 and has a history of 28 years and five months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.22 M.
The company currently has active open charges totaling ₹1.57 Cr. The company has closed loans amounting to ₹1.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shrikant Deshpande, Swati Deshpande, Avinash Sanas, and One other member serve as directors at the Company.
Gandhi Nagar, Gujarat, India
+91-XXXXXXXXXX
-
U24231GJ1996PTC030650
030650
Private Limited Indian Non-Government Company
06 Sep 1996
30 Sep 2023
31 Mar 2023
Unlisted
Roc Ahmedabad
Romano Drugs Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shrikant Deshpande ![]() | Director | 06-Sep-1996 | Current |
Swati Deshpande ![]() | Director | 05-Jun-2023 | Current |
Avinash Sanas ![]() | Additional Director | 05-Feb-2024 | Current |
Mohit Chhajed ![]() | Additional Director | 05-Feb-2024 | Current |
Romano Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.23% increase. The company also saw a slight decrease in profitability, with a 9.81% decrease in profit. The company's net worth Soared by an impressive increase of 230.8%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Romano Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Avinash Sanas is a mutual person
₹15.70 M
₹10.30 M
Date | Lender | Amount | Status |
---|---|---|---|
30 Sep 2023 | Others | ₹1.57 Cr | Open |
07 Aug 2012 | Punjab National Bank | ₹8.00 M | Satisfied |
17 Nov 1998 | Gujarat State Financial Corporation | ₹2.30 M | Satisfied |
Unlock and access historical data on people associated with Romano Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Romano Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Romano Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Avinash Tukaram Sanas was appointed as a Additional Director was appointed as a Additional Director on 05 Feb 2024 & has been associated with this company since 1 year 28 days .
Mohit Chhajed was appointed as a Additional Director was appointed as a Additional Director on 05 Feb 2024 & has been associated with this company since 1 year 28 days .
A charge with Others amounted to Rs. 15.70 M with Charge ID 100794557 was registered on 30 Sep 2023.
Romano Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Swati Shrikant Deshpande was appointed as a Director was appointed as a Director on 05 Jun 2023 & has been associated with this company since 1 year 9 months .
Romano Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
Romano Drugs Private Limited was incorporated on 06 Sep 1996.
The authorized share capital of Romano Drugs Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.22 M.
Currently 4 directors are associated with Romano Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Romano Drugs Private Limited is 9/B Trimul Estate Nr. Lincoin Pharma Po.: Khatraj, Ta. Kalol India, Gandhinahar, Gujarat, 382721.
The corporate identification number (CIN) of Romano Drugs Private Limited is U24231GJ1996PTC030650 and the company number is 030650 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Romano Drugs Private Limited has risen by 48.23%.
The financial reports for the fiscal year 2022 indicates that The net worth of Romano Drugs Private Limited has experienced an upsurge of 230.80%.
As per the financial statements for fiscal Year 2022, The total open charges for Romano Drugs Private Limited amount to ₹ 1.57 Cr.
The most recent Balance Sheet for Romano Drugs Private Limited was filed with the ROC on 31 Mar 2023.
RP
JS
KP